袁霞

作品数:9被引量:14H指数:2
导出分析报告
供职机构:北京大学更多>>
发文主题:YCOMPOUND蛋白酶体抑制剂CELL_CYCLE_ARRESTCELL-CYCLE更多>>
发文领域:医药卫生理学化学工程更多>>
发文期刊:《生物化学与生物物理进展》《中国药理学通报》《Journal of Chinese Pharmaceutical Sciences》更多>>
所获基金:国家自然科学基金国家科技重大专项“重大新药创制”科技重大专项更多>>
-

检索结果分析

署名顺序

  • 全部
  • 第一作者
结果分析中...
条 记 录,以下是1-9
视图:
排序:
Effects and mechanism of proteasome inhibitor YSY01--A alone or in combination with cisplatin against A549 cells in vitro被引量:2
《Journal of Chinese Pharmaceutical Sciences》2015年第9期607-616,共10页孙婷 袁霞 黄薇 郭维 葛泽梅 李润涛 崔景荣 
Eleventh Five-Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930010);National Science Foundation of China(Grant No.81172915);a grant from Major New Drug Research and Development Platform of Peking University(GrantNo.2009ZX09301010)
YSY01-A, as a novel proteasome inhibitor, has shown remarkable proliferation inhibitory effect on certain types of tumor cells. However, few studies have reported its effect on non-small cell lung cancer (NSCLC), an...
关键词:Proteasome inhibitor A549 Cisplatin combination PTEN CTR1 ANTITUMOR 
Effects of compound YSY-01A, a novel proteasome inhibitor, on MGC-803 cells and its related mechanism
《Journal of Chinese Pharmaceutical Sciences》2014年第9期601-609,共9页陈溢欣 袁霞 葛泽梅 冉福香 吴军 李润涛 崔景荣 
Eleventh Five-Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930-010);National Science Foundation of China(Grant No.81172915);a grant from Major New Drug Research and Development Platform of PekingUniversity(Grant No.2009ZX09301-010)
As a novel proteasome inhibitor, remarkable proliferation inhibitory effect of compound YSY-01A was shown on tumor cells in previous studies. However, few studies has reported its effect on gastric cancer and related ...
关键词:Proteasome inhibitor YSY-01A MGC-803 cell line NF-KB ANTI-TUMOR 
A new proteasome inhibitor YSY-01A induced autophagy in PC-3M cells被引量:1
《Journal of Chinese Pharmaceutical Sciences》2014年第8期565-571,共7页王喆 袁霞 葛泽梅 冉福香 吴军 李润涛 崔景荣 
Eleventh Five-Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930-010);National Science Foundation of China(Grant No.81172915);a grant from Major New Drugs Research and Development Platform of Peking University(Grant No.2009ZX09301-010)
YSY-01A has shown proliferation inhibitory activity to certain types of tumor cells by inhibiting proteasome. How- ever, its effect on autophagy, which is related with the ubiquitin proteasome pathway (UPP), remains...
关键词:Proteasome inhibitor YSY-01 A PC-3M AUTOPHAGY 
蛋白酶体抑制剂YSY01A不依赖NF-κB通路抑制乳腺癌细胞增殖及诱导凋亡研究被引量:2
《中国药理学通报》2014年第3期34-39,共6页张梅 袁霞 徐波 冉福香 吴军 葛泽梅 李润涛 崔景荣 
国家科技部"重大新药创制"科技专项基金(No2009ZX0930010);国家自然科学基金资助项目(No81172915)
目的研究YSY01A对乳腺癌的增殖抑制作用及其抗癌机制。方法荧光底物法检测蛋白酶体活性;蛋白酶体荧光探针法研究YSY01A与蛋白酶体β催化亚基结合;Annexin V-FITC、JC-1探针检测YSY01A对细胞凋亡和线粒体膜电位的影响;用蛋白免疫印迹法...
关键词:蛋白酶体 抑制剂 增殖 凋亡 NF-ΚB 乳腺癌 
DNA damaging effect of SLXM-2, a derivative of cyclophosphamide, on hepatocarcinoma H_(22) cells in vivo
《Journal of Chinese Pharmaceutical Sciences》2014年第1期16-21,共6页楚明明 袁霞 贾璇 孙婷 郭维 蒋晓 刘敬弢 李润涛 崔景荣 
Eleventh Five Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930010)
Compound SLXM-2, a derivative of cyclophosphamide (CTX), has shown potent growth-inhibitory effect on tumor cells with low toxicity in previous studies. However, the mechanism of its anti-tumor effect, especially on...
关键词:SLXM-2 H22 DNA damage SCGE DNA damage-related proteins 
新型蛋白酶体抑制剂YSY-01A对肿瘤细胞促血管生成作用的抑制及其机制初探被引量:11
《生物化学与生物物理进展》2013年第8期748-756,共9页刘敬弢 袁霞 徐波 冉福香 楚明明 贾璇 陈溢欣 王哲 李润涛 崔景荣 
国家“十一五”科技重大专项:北京大学综合性创新药物研究开发技术大平台(2009ZX09301-010)~~
YSY-01A是一种新型蛋白酶体抑制剂,前期研究已经证实其对肿瘤细胞的增殖有抑制作用.但是它对肿瘤血管生成是否有影响尚不明确.本研究旨在探明YSY-01A阻碍肿瘤细胞促进血管生成的作用及机制.我们首先将磺酰罗丹明B(sulforhodamine B,SRB...
关键词:蛋白酶体抑制剂 血管生成 人脐静脉内皮细胞 HT-29细胞 高内涵筛选 YSY-01A 
Cell cycle arrest effect of compound YSY-01A, a new proteasome inhibitor,on SK-OV-3 cells被引量:1
《Journal of Chinese Pharmaceutical Sciences》2013年第6期483-490,共8页贾璇 袁霞 楚明明 冉福香 李润涛 崔景荣 
Eleventh Five-Year Plan for National Science and Technology Major Project(Grant No.2009ZX0930-010);National Science Foundation of China(Grant No.81172915);a grant from Major New Drugs Research and Development Platform of Peking University(Grant No.2009ZX09301-010)
Compound YSY-01A, a recently synthesized proteasome inhibitor, has shown potent growth-inhibitory effect on tumor cells in previous researches. However, the mechanism of its inhibitory effects, especially on cell cycl...
关键词:Proteasome inhibitor YSY-01A SK-OV-3 Cell-cycle related protein High content screening 
Effects of compound 209 on colorectal cancer cell HT-29 in vivo and in vitro
《Journal of Chinese Pharmaceutical Sciences》2013年第1期89-94,共6页蒋晓 袁霞 楚明明 郭维 刘敬弢 冉福香 葛泽梅 李润涛 崔景荣 
China International Science and Technology Cooperation Program for Key Projects (Grant No. 2008DFA31070)
Compound 209 is a newly synthesized dithiocarbamate derivative with antiproliferation activity in vitro, however, its antitumor effect in vivo and the underlying mechanisms have yet to be identified. We explored the a...
关键词:DITHIOCARBAMATE Compound 209 Cell cycle Cell cycle-related proteins HT-29 cell line 
Cell cycle arrest effect of compound YSY-01A, a new proteasome inhibitor, on HT-29 cells in vitro被引量:1
《Journal of Chinese Pharmaceutical Sciences》2012年第5期448-458,共11页佟侃 刘敬弢 袁霞 徐波 郭维 韩利强 姚书扬 葛泽梅 李润涛 崔景荣 
Eleventh Five-Year Plan for National Science and Technology Major Project (Grant No.2009ZX0930-010);National Science Foundation of China (NSFC81172915);A grant from Major New Drugs Research and Development Platform of Peking University (Grant No.2009ZX09301-010)
Compound YSY-01A, a recently synthesized proteasome inhibitor, has shown potent growth-inhibitory effect on tumor cells in previous researches. However, the mechanism of its inhibitory effects, especially on cell cycl...
关键词:Proteasome inhibitor YSY-01A HT-29 Cell-cycle related protein HCS 
检索报告 对象比较 聚类工具 使用帮助 返回顶部